NEW YORK (GenomeWeb News) – Shares in Third Wave Technologies were up 13 percent, or $.31, at $2.66 in mid-afternoon trading today after the company said second-quarter revenues increased while net loss narrowed.
 
As GenomeWeb News reported this morning, Third Wave said revenues increased approximately 17 percent and net losses declined. Clinical molecular diagnostic receipts jumped 18 percent.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.